Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

819 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Completed

Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC

NCT03289819

Conditions
Breast Diseases, Breast Neoplasms, Malignant Neoplasm of Breast, +5 more
Locations
  • Department of Gynecology, Tübingen University Hospital Tübingen, Baden-Wurttemberg, Germany
  • Department of Gynecology and Obstetrics, Erlangen University Hospital Erlangen, Bavaria, Germany
  • Department for Gynecology and Obstetrics, Marienhospital Bottrop gGmbH Bottrop, North Rhine-Westphalia, Germany
  • Department of Gynecology and Obstetrics, HELIOS Hospital Berlin Buch GmbH Berlin, Germany
View Trial Details
Completed

A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer

NCT02032277

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Scottsdale Healthcare /ID# 120473 Scottsdale, Arizona, United States
  • Mayo Clinic - Scottsdale /ID# 139932 Scottsdale, Arizona, United States
  • Arizona Oncology Associates, PC-HOPE /ID# 126137 Tucson, Arizona, United States
  • Usc /Id# 123310 Los Angeles, California, United States
View all 158 locations
View Trial Details
Completed

PCA062 in pCAD-positive Tumors.

NCT02375958

Conditions
Breast Diseases, Breast Neoplasms, Digestive System Diseases, +14 more
Locations
  • Novartis Investigative Site Houston, Texas, United States
  • Novartis Investigative Site San Antonio, Texas, United States
  • Novartis Investigative Site Villejuif, France
  • Novartis Investigative Site Milan, MI, Italy
View Trial Details
Completed

A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors

NCT02222922

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +29 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Scottsdale Healthcare Hospitals DBA HonorHealth Scottsdale, Arizona, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 17 locations
View Trial Details
Completed

A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients

NCT01155453

Conditions
Advanced and Selected Solid Tumors, Breast Diseases, Breast Neoplasms, +11 more
Locations
  • University of California at Los Angeles Div. of Hematology/Oncology Los Angeles, California, United States
  • University of Texas/MD Anderson Cancer Center Dept of MD Anderson (8) Houston, Texas, United States
  • Novartis Investigative Site Leuven, Belgium
  • Novartis Investigative Site Toronto, Ontario, Canada
View Trial Details
Completed

IACS-010759 in Advanced Cancers

NCT03291938

Conditions
Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +46 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions